Latest Reports
Immune Biomarkers Market - Strategic Insights and Forecasts (2026-2035)
The immune biomarkers market supports the identification, measurement, and interpretation of immune system activity across disease diagnosis, treatment selection, therapeutic monitoring, and drug development. The market functions as a found...
Companion Diagnostics Clinical Development Market - Strategic Insights and Forecasts (2026-2035)
The Companion Diagnostics Clinical Development Market supports the identification, validation, and regulatory qualification of biomarkers that guide patient selection for targeted therapies. The market functions as a critical component of p...
KRAS Companion Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The KRAS Companion Diagnostics Market supports the identification of patients eligible for KRAS-targeted therapies through molecular testing technologies that detect clinically actionable KRAS mutations. The market functions as a foundation...
Hospital-Acquired Infection Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The Hospital-Acquired Infection (HAI) Diagnostics Market supports the identification of infections acquired during healthcare delivery through microbiology, molecular diagnostics, immunoassays, and rapid testing platforms. The market serves...
HER2 Companion Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The HER2 Companion Diagnostics Market supports the identification of patients eligible for HER2-targeted therapies across multiple oncology indications. The market functions as a critical component of precision medicine because therapeutic ...
Hematology Companion Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The Hematology Companion Diagnostics Market supports precision treatment selection across hematologic malignancies by identifying biomarkers that predict therapeutic response, resistance patterns, and disease progression. The market functio...
EGFR Companion Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The EGFR Companion Diagnostics Market supports the identification of patients eligible for EGFR-targeted therapies across multiple oncology indications, particularly in non-small cell lung cancer (NSCLC) and other solid tumors. The market s...
Companion Diagnostics Software Market - Strategic Insights and Forecasts (2026-2035)
Companion diagnostics software enables the interpretation, management, and clinical application of molecular and genomic data used to guide targeted therapeutic decisions. The market functions as a digital infrastructure layer connecting se...
Companion Diagnostics Services Market - Strategic Insights and Forecasts (2026-2035)
The Companion Diagnostics Services Market supports pharmaceutical and biotechnology companies in developing, validating, and commercializing diagnostic assays that identify patients most likely to benefit from targeted therapies. These serv...
BRAF Companion Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The BRAF Companion Diagnostics Market supports the identification of patients eligible for targeted therapies through molecular testing that detects clinically actionable BRAF mutations. The market functions as a critical component of preci...
STI Diagnostics Market - Strategic Insights and Forecasts (2026-2035)
The STI diagnostics market supports the identification, screening, and monitoring of sexually transmitted infections through laboratory-based and point-of-care diagnostic technologies. Demand is increasing because healthcare systems are exp...
Sepsis Diagnostics Market Growth & Forecast (2026-2035)
The sepsis diagnostics market encompasses diagnostic technologies, laboratory systems, biomarkers, molecular platforms, and clinical decision-support tools used to identify sepsis and guide timely therapeutic intervention. The market functi...
Related Intelligence Hubs
Explore interconnected markets and cross-industry research.